The spread of drug-resistant tuberculosis in children: An Italian case series

Epidemiology and Infection

Volumn 142, Issue 10, 2014, Pages 2049-2056

  Mignone, F ^a   Codecasa, L R ^b   Scolfaro, C ^a   Raffaldi, I ^a   Lancella, L ^c   Ferrarese, M ^b   Garazzino, S ^a   Marabotto, C ^c   Esposito, S ^d   Gabiano, C ^a   Lipreri, R ^b   Tovo, P A ^a  

^a REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^b Regional Tuberculosis Reference Centre   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Adolescent; children; drug resistance; treatment; tuberculosis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; CLOFAZIMINE; ETHAMBUTOL; ISONIAZID; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; AMINOSALICYLIC ACID; CYCLOSERINE; ETHIONAMIDE; KANAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADVERSE OUTCOME; ARTICLE; BACTERIAL TRANSMISSION; BONE MARROW TOXICITY; CHILD; CHILD HEALTH; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ACTIVITY; DRUG EFFECT; DRUG RESISTANT TUBERCULOSIS; DRUG SAFETY; FEMALE; FOLLOW UP; HEPATITIS; HUMAN; INFANT; ITALY; LEG PAIN; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; OUTCOME ASSESSMENT; PRESCHOOL CHILD; TREATMENT DURATION; TREATMENT PLANNING; TREND STUDY; VOMITING; ADD ON THERAPY; CASE STUDY; CHILDHOOD; INCIDENCE; MEDICAL HISTORY; TERTIARY CARE CENTER; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUBERCULOUS OSTEOMYELITIS; TUBERCULOUS SPONDYLITIS;

ADOLESCENT; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EMIGRATION AND IMMIGRATION; FEMALE; HUMANS; INFANT; ITALY; MALE; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84906274578     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813003191     Document Type: Article

References (34)

1. World Health Organization. Global tuberculosis report 2012. WHO/HTM/TB/20126. Geneva, Switzerland: WHO, 2012.
2. Syridou G, et al. Trends in epidemiology of childhood tuberculosis in Greece. International Journal of Tuberculosis and Lung Disease 2012; 16: 749-755.
3. World Health Organization. The WHO/IUATLD Global Project of Anti-Tuberculosis Drug Resistance Surveillance. Antituberculosis drug resistance in the world. WHO/HTM/TB/2008394. Geneva, Switzerland: WHO. 2008.
4. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2012. Stockholm: European Centre for Disease Prevention and Control, 2012 (www.ecdc.europa.eu/en/ publications/Publications/1203-Annual-TB-Report.pdf). Accessed 3 December 2012.
5. Sandgren A, et al. Childhood tuberculosis in the European Union/European Economic Area, 2000 to 2009. Eurourveillance 2011; 16: pii=19825.
6. Italian National Health Service. Report: Tuberculosis in Italy-2008 [in Italian] (http://www.epicentro.iss.it/problemi/Tubercolosi/epid.asp). Accessed 3 December 2012.
7. Seddon JA, et al. Caring for children with drugresistant tuberculosis. Practice-based recommendations. American Journal Respiratory Critical Care Medicine 2012; 186: 953-964.
8. Schaaf HS, Marais BJ. Management of multidrugresistant tuberculosis in children: a survival guide for paediatricians. Paediatric Respiratory Review 2011; 12: 31-38.
9. World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. WHO/HTM/TB/2006371. Geneva, Switzerland: WHO, 2006.
10. Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. Morbidity and Mortality Weekly Report 2006; 55: 301-305.
11. Centers for Disease Control and Prevention. Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Weekly Epidemiological Record 2006; 81: 430-432.
12. World Health Organization. Treatment of Tuberculosis: Guidelines, 4th edn. WHO/HTM/TB/2009420. Geneva, Switzerland: WHO, 2009.
13. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency update 2008. WHO/HTM/TB/2008402. Geneva, Switzerland: WHO, 2008.
14. Seddon JA, et al. Pediatric use of second-line antituberculosis agents: a review. Tuberculosis 2012; 92: 9-17.
15. Curry FJ. Drug-resistant tuberculosis: a survival guide for clinicians. Curry International Tuberculosis Center (http://www.nationaltbcenter.edu/drtb). Accessed 6 April 2013.
16. Pinon M, et al. Two pediatric cases of multidrugresistant tuberculosis treated with linezolid and moxifloxacin. Pediatrics 2010; 126: e1253-1256.
17. World Health Organization. Rapid advice: treatment of tuberculosis in children. WHO/HTM/TB/201013. Geneva, Switzerland: WHO, 2010.
18. Burki T. Surveillance, co-infection, resistance: tuberculosis in Europe. Lancet Infectious Diseases 2011; 11: 333.
19. Esposito S, et al. Peritoneal tuberculosis due to multidrug-resistant Mycobacterium tuberculosis. Pediatrics International 2013; 55: e20-22.
20. Garazzino S, et al. Moxifloxacin for the treatment of pulmonary tuberculosis in children: a single center experience. Pediatric Pulmonology. Published online: 8 February 2013. doi:10.1002/ppul.22755.
21. Mauro MV, et al. Description of primary multidrugresistant tuberculous meningitis in an Italian child. Microbial Drug Resistance 2012; 18: 71-73.
22. Leung EC, et al. Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city. European Respiratory Journal 2013; 41: 901-908.
23. Chiang C-Y, Schaaf HS. Management of drug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease 2010; 14: 672-682.
24. Sotgiu G, et al. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. European Respiratory Journal 2009; 33: 871-881.
25. Al-Dabbagh M, et al. Drug-resistant tuberculosis: pediatric guidelines. Pediatric Infectious Disease Journal 2011; 30: 501-505.
26. Vijayasekaran D. Treatment of childhood tuberculosis. Indian Journal of Pediatrics 2011; 78: 443-448.
27. Chauny JV, et al. Treatment of tuberculosis with levofloxacin or moxifloxacin: report of six pediatric cases. Pediatric Infectious Disease Journal 2012; 31: 1309-1311.
28. Fortún J, et al. Linezolid for the treatment of multidrug-resistant tuberculosis. Journal of Antimicrobial Chemotherapy 2005; 56: 180-185.
29. Condos R, et al. Case series report of a linezolidcontaining regimen for extensively drug-resistant tuberculosis. Chest 2008; 134: 187-192.
30. Schecter GF, et al. Linezolid in the treatment of multidrug-resistant tuberculosis. Clinical Infectious Diseases 2010; 50: 49-55.
31. Schaaf HS, Willemse M, Donald PR. Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis. Pediatric Infectious Disease Journal 2009; 28: 748-750.
32. Anger HA, et al. Linezolid use for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-2006. Journal of Antimicrobial Chemotherapy 2010; 65: 775-783.
33. Rose PC, et al. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children. International Journal of Tuberculosis and Lung Disease 2012; 16: 1588-1593.
34. Zignol M, et al. Multidrug-resistant tuberculosis in children: evidence from global surveillance. European Respiratory Journal 2013; 42: 701-707.